Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion type Assertion NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_head.
- NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion description "[Compounds that inhibit kinase activity are effective growth inhibitors for poorly differentiated thyroid cancer cell lines with either RET or RAF mutations, and hold promise for treatment of most forms of papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_provenance.
- NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion evidence source_evidence_literature NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_provenance.
- NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion SIO_000772 16551863 NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_provenance.
- NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion wasDerivedFrom befree-20140225 NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_provenance.
- NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_assertion wasGeneratedBy ECO_0000203 NP651050.RAtPhaStK5hkq0x2ly_4OkkiAmOzuLTVI2I3dXONEGylg130_provenance.